We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hold Partly Removed from Corautus Genetics Clinical Trial
Hold Partly Removed from Corautus Genetics Clinical Trial
July 26, 2006
The FDA has partially lifted the clinical hold it imposed March 29 on Corautus Genetics’ GENASIS Phase IIb clinical trial of its VEGF-2 therapy for cardiovascular disease and peripheral vascular disease.